Abstract
The cerebral and lung kinetics of the enantiomers of methadone were quantified using a conscious chronically instrumented sheep preparation, as these organs are the major organs governing the peak brain concentrations (and therefore effects) of methadone after ivbolus administration. Seven sheep were administered intravenous infusions of rac-methadone (30 mg over 4 min). Whole blood (R)- and (S)-methadone concentrations were measured using stereoselective HPLC. Methadone transiently increased cardiac output (CO) and mean arterial pressure, but did not alter cerebral blood flow (CBF) or cause significant respiratory depression. Using physiologically based kinetic models, cerebral kinetics were inferred from arterio-sagittal sinus concentration gradients and CBF, lung kinetics from pulmonary artery-aortic gradient and CO. Lung and cerebral kinetics were best described by a partially membrane-limited model for both enantiomers. Lung kinetics displayed clear stereoselectivity, due to the smaller apparent volume of the deep lung compartment for (R)-methadone (45 l) compared to (S)-methadone (79 l). This resulted in systemic differences in the concentrations of the enantiomers. Minimal stereoselectivity was observed in cerebral kinetics. The brain:blood equilibration of methadone was slow (half-life of 18 min) due to intermediate permeability and large apparent cerebral distribution volumes. However, the permeability term was sufficiently high that cerebral kinetics were affected by CBF. Simulations demonstrated that if CBF was doubled, the equilibration half-life of methadone with brain tissue decreased by 30%, and there was a 25% increase in the peak brain concentrations. Future studies are needed to confirm the role of cerebral blood flow alterations in the exposure of the brain to methadone, especially in the case of respiratory depression. In conclusion, pharmacokinetic modelling of methadone confirmed a large equilibration delay between brain and blood.
Similar content being viewed by others
References
M. Farrell J. Ward R. Mattick W. Hall G.V Stimson D. Jarlais Particledes M. Gossop J. Strang (1994) ArticleTitleMethadone maintenance treatment in opiate dependence: a review BMJ 309 997–1001 Occurrence Handle7950725 Occurrence Handle1:STN:280:DyaK2M%2FjvVWntQ%3D%3D
E.E. Codd R.P. Shank J.J Schupsky R.B. Raffa (1995) ArticleTitleSerotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception J. Pharmacol. Exp Ther. 274 1263–1270 Occurrence Handle7562497 Occurrence Handle1:CAS:528:DyaK2MXot1yjsb4%3D
K. Kristensen C.B. Christensen L.L. Christrup (1995) ArticleTitleThe μ1, μ2, δ, κ opioid receptor binding profiles of methadone stereoisomers and morphine Life Sci. 56 45–50 Occurrence Handle10.1016/0024-3205(94)00426-S
C.C. Scott E.B. Robbins K.K. Chen (1948) ArticleTitlePharmacologic comparison of the optical isomers of methadon J. Pharmacol Exp. Ther. 93 282–286 Occurrence Handle1:CAS:528:DyaH1cXjsV2lsQ%3D%3D Occurrence Handle18882133
H. Isbell A.J. Eisenman (1948) ArticleTitleThe addiction liability of some of the drugs of the methadon series J. Pharmacol. Exp Ther. 93 305–313 Occurrence Handle1:CAS:528:DyaH1cXjsV2ltw%3D%3D Occurrence Handle18882136
G.D. Olsen H.A. Wendel J.D. Livermore R.M. Leger R.K Lynn N. Gerber (1977) ArticleTitleClinical effects and pharmacokinetics of racemic methadone and its optical isomers Clin. Pharmacol Ther. 21 147–157 Occurrence Handle837634 Occurrence Handle1:CAS:528:DyaE2sXhtlektL0%3D
K. Kristensen T. Blemmer H.R. Angelo L.L. Christrup N.E Drenck S.N. Rasmussen P. Sjøgren (1996) ArticleTitleStereoselective pharmacokinetics of methadone in chronic pain patients Ther Drug Monit. 18 221–227 Occurrence Handle10.1097/00007691-199606000-00001 Occurrence Handle8738759 Occurrence Handle1:CAS:528:DyaK28XjvFOkt7w%3D
D.J.R. Foster A.A. Somogyi J.M. White F. Bochner (2004) ArticleTitlePopulation pharmacokinetics of (R)-, (S)- and rac-methadone in methadone maintenance patients Br. J. Clin. Pharmacol. 57 742–755 Occurrence Handle10.1111/j.1365-2125.2004.02079.x Occurrence Handle15151520 Occurrence Handle1:CAS:528:DC%2BD2cXls1SisLw%3D
D.J.R. Foster A.A. Somogyi K.R. Dyer J.M. White F Bochner (2000) ArticleTitleSteady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients Br. J. Clin. Pharmacol. 50 427–440 Occurrence Handle10.1046/j.1365-2125.2000.00272.x Occurrence Handle11069437 Occurrence Handle1:CAS:528:DC%2BD3cXos1Olt7k%3D
C. Ripamonti E.D. Dickerson (2001) ArticleTitleStrategies for the treatment of cancer pain in the new millennium Drugs 61 955–977 Occurrence Handle11434451 Occurrence Handle1:CAS:528:DC%2BD3MXltFejtLc%3D
E. Bruera C. Sweeney (2002) ArticleTitleMethadone use in cancer patients with pain: a review J. Palliat. Med. 5 127–138 Occurrence Handle11839235
M.J. Garrido I.F. Troconiz (1999) ArticleTitleMethadone: a review of its pharmacokinetic/pharmacodynamic properties J. Pharmacol Toxicol. Methods 42 61–66 Occurrence Handle10.1016/S1056-8719(00)00043-5 Occurrence Handle10924887 Occurrence Handle1:CAS:528:DC%2BD3cXlt1Kgur0%3D
S.L. Shafer J.R. Varvel (1991) ArticleTitlePharmacokinetics, pharmacodynamics, and rational opioid selection Anesthesiology 74 53–63 Occurrence Handle1824743 Occurrence Handle1:CAS:528:DyaK3MXhvF2ntLc%3D
R.N. Upton T.J. Semple P.E. Macintyre (1997) ArticleTitlePharmacokinetic optimisation of opioid treatment in acute pain therapy Clin. Pharmacokinet. 33 225–244 Occurrence Handle9314613 Occurrence Handle1:CAS:528:DyaK2sXmsVelur0%3D
E.D. Kharasch C. Hoffer D. Whittington (2004) ArticleTitleThe effect of quinidine, used as a probe for the involvement of P-glycoprotein, on the intestinal absorption and pharmacodynamics of methadone Br J. Clin. Pharmacol. 57 600–610 Occurrence Handle1:CAS:528:DC%2BD2cXksF2ktbo%3D
D.W. Boulton P. Arnaud C.L. DeVane (2001) ArticleTitlePharmacokinetics and pharmacodynamics of methadone enantiomers after a single oral dose of racemate Clin. Pharmacol. Ther. 70 48–57 Occurrence Handle10.1067/mcp.2001.116793 Occurrence Handle11452244 Occurrence Handle1:CAS:528:DC%2BD3MXlvFKqsr4%3D
C.E. Inturrisi R.K. Portenoy M.B. Max W.A. Colburn K.M. Foley (1990) ArticleTitlePharmacokinetic–pharmacodynamic relationships of methadone infusions in patients with cancer pain Clin Pharmacol. Ther. 47 565–577 Occurrence Handle2188771 Occurrence Handle1:STN:280:DyaK3c3mtlentQ%3D%3D Occurrence Handle10.1038/clpt.1990.77
C.E. Inturrisi W.A. Colburn R.F. Kaiko R.W. Houde K.M. Foley (1987) ArticleTitlePharmacokinetics and pharmacodynamics of methadone in patients with chronic pain Clin. Pharmacol. Ther. 41 392–401 Occurrence Handle3829576 Occurrence Handle1:STN:280:DyaL2s7mtVensQ%3D%3D Occurrence Handle10.1038/clpt.1987.47
W.H. Oldendorf S. Hyman L. Braun S.Z. Oldendorf (1972) ArticleTitleBlood–brain barrier: penetration of morphine, codeine, heroin, and methadone after carotid injection Science 178 984–986 Occurrence Handle5084666 Occurrence Handle1:CAS:528:DyaE3sXlt1Omug%3D%3D
C.-Y. Sung E.L. Way (1953) ArticleTitleThe metabolic fate of the optical isomers of methadone J. Pharmacol. Exp. Ther. 109 244–254 Occurrence Handle13109683 Occurrence Handle1:CAS:528:DyaG2cXhsFyisA%3D%3D
A.L. Misra S.J. Mulé (1972) ArticleTitlePersistence of methadone−3H and metabolite in rat brain after a single injection and its implications on pharmacological tolerance Nature 238 155–157 Occurrence Handle10.1038/238155a0 Occurrence Handle4558456 Occurrence Handle1:CAS:528:DyaE38XltV2htLg%3D
E.H. Harte C.L. Gutjahr M.J. Kreek (1974) ArticleTitleLong-term persistence of DL-methadone in tissues Clin. Res. 24 623A
N.S. Shah A.G. Donald J.A. Bertolatus B. Hixson (1976) ArticleTitleTissue distribution of levo-methadone in nonpregnant and pregnant female and male mice: effect of SKF 525-A J. Pharmacol. Exp Ther. 199 103–116 Occurrence Handle978473 Occurrence Handle1:CAS:528:DyaE28XlsFeksb0%3D
A.E. Robinson F.M. Williams (1971) ArticleTitleThe distribution of methadone in man J. Pharm. Pharmacol. 23 353–358 Occurrence Handle4396979 Occurrence Handle1:CAS:528:DyaE3MXktVertLw%3D
R.N. Upton D.J. Doolette (1999) ArticleTitleKinetic aspects of drug disposition in the lungs Clin. Exp. Pharmacol. Physiol. 26 381–391 Occurrence Handle10.1046/j.1440-1681.1999.03048.x Occurrence Handle10386226 Occurrence Handle1:CAS:528:DyaK1MXksFeqs7k%3D
D.J. Doolette R.N. Upton C. Grant (1999) ArticleTitleAgreement between ultrasonic Doppler venous outflow and Kety and Schmidt estimates of cerebral blood flow Clin. Exp. Pharmacol. Physiol. 26 736–740 Occurrence Handle10.1046/j.1440-1681.1999.03109.x Occurrence Handle10499164 Occurrence Handle1:CAS:528:DyaK1MXmtFCnt70%3D
R. Upton C. Grant G. Ludbrook (1994) ArticleTitleAn ultrasonic Doppler venous outflow method for the continuous measurement of cerebral blood flow in conscious sheep J. Cereb. Blood Flow Metab. 14 680–688 Occurrence Handle8014216 Occurrence Handle1:STN:280:DyaK2c3osVejug%3D%3D
M. Longley S.H. Phua T.C. Stijn Particlevan A.M. Crawford (1999) ArticleTitleIsolation and mapping of the first ruminant multidrug resistance genes Anim. Genet. 30 207–210 Occurrence Handle10.1046/j.1365-2052.1999.00465.x Occurrence Handle10442984 Occurrence Handle1:CAS:528:DyaK1MXltVKit7s%3D
R.N. Upton G.L. Ludbrook E.C. Gray C. Grant (1997) ArticleTitleThe cerebral pharmacokinetics of meperidine and alfentanil in conscious sheep Anesthesiology 86 1317–1325 Occurrence Handle9197301 Occurrence Handle1:CAS:528:DyaK2sXktlWgtLo%3D
R.N. Upton G.L. Ludbrook C. Grant D.J. Doolette (2000) ArticleTitleThe effect of altered cerebral blood flow on the cerebral kinetics of thiopental and propofol in sheep Anesthesiology 93 1085–1094 Occurrence Handle11020765 Occurrence Handle1:CAS:528:DC%2BD3cXnsFGjt7w%3D
R.N. Upton G.L. Ludbrook A.M. Martinez C. Grant RW. Milne (2003) ArticleTitleCerebral and lung kinetics of morphine in conscious sheep after short intravenous infusions Br. J. Anaesth. 90 750–758 Occurrence Handle10.1093/bja/aeg131 Occurrence Handle12765891 Occurrence Handle1:CAS:528:DC%2BD3sXkt1Wrsro%3D
Michenfelder J.D. Cerebral blood flow and metabolism In Clinical Neuroanesthesia. J. D. Michenfelder (ed.) Churchill Livingstone, Melbourne, Australia, pp. 1–40
L.E. Mather M.J. Cousins Y.F. Huang M.E. Pryor SM. Barratt (2000) ArticleTitleLack of secondary hyperalgesia and central sensitization in an acute sheep model Reg. Anesth. Pain Med. 25 174–180 Occurrence Handle10.1053/rapm.2000.0250174 Occurrence Handle10746531 Occurrence Handle1:STN:280:DC%2BD3c3gvVehsg%3D%3D
S.A. Schug D. Zech S. Grond (1992) ArticleTitleAdverse effects of systemic opioid analgesics Drug Saf. 7 200–213 Occurrence Handle1354445 Occurrence Handle1:STN:280:DyaK38zmvVCrug%3D%3D
M.W. Anderson T.C. Orton R.D. Pickett T.E. Eling (1974) ArticleTitleAccumulation of amines in the isolated perfused rabbit lung J. Pharmacol. Exp. Ther. 189 456–466 Occurrence Handle4151395 Occurrence Handle1:CAS:528:DyaE2cXksFyiur4%3D
D.L. Roerig C.A. Dawson R.I. Wang (1982) ArticleTitleUptake and efflux of l-α-acetylmethadol (LAAM) and methadone in the isolated perfused rat lung Drug Metab. Dispos. 10 230–235 Occurrence Handle6125355 Occurrence Handle1:CAS:528:DyaL38XksV2htLw%3D
D.L. Roerig R.R. Dahl C.A. Dawson R.I. Wang (1984) ArticleTitleEffect of plasma protein binding on the uptake of methadone and diazepam in the isolated perfused rat lung Drug Metab Dispos. 12 536–542 Occurrence Handle6149902 Occurrence Handle1:CAS:528:DyaL2cXlvVentr0%3D
H.R. Sullivan S.L. Due (1973) ArticleTitleUrinary metabolites of DL-methadone in maintenance subjects J. Med. Chem. 16 909–913 Occurrence Handle10.1021/jm00266a009 Occurrence Handle4745834 Occurrence Handle1:CAS:528:DyaE2cXhtVaitA%3D%3D
J.L. Gabrielsson P. Johansson U. Bondesson L.K Paalzow (1985) ArticleTitleAnalysis of methadone disposition in the pregnant rat by means of a physiological flow model J Pharmacokinet. Biopharm. 13 355–372 Occurrence Handle10.1007/BF01061474 Occurrence Handle4087168 Occurrence Handle1:CAS:528:DyaL28XmtFCqtA%3D%3D
J.L. Gabrielsson T. Groth (1988) ArticleTitleAn extended physiological pharmacokinetic model of methadone disposition in the rat: validation and sensitivity analysis J Pharmacokinet. Biopharm. 16 183–201 Occurrence Handle10.1007/BF01062260 Occurrence Handle3418495 Occurrence Handle1:CAS:528:DyaL1cXltVCisrk%3D
R.N. Upton (2000) ArticleTitleRelationships between steady state blood concentrations and cardiac output during intravenous infusions Biopharm Drug Dispos. 21 69–76 Occurrence Handle1:CAS:528:DC%2BD3cXotlWmtb4%3D
A.L. Misra S.J. Mulé (1973) ArticleTitleStereoselectivity and differential metabolism in vivo of dextro and laevo-methadone-1−3H Nature 241 281–283 Occurrence Handle10.1038/241281a0 Occurrence Handle4550034 Occurrence Handle1:CAS:528:DyaE3sXhtVGrurw%3D
J.E. Shook W.D. Watkins E.M. Camporesi (1990) ArticleTitleDifferential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression Am. Rev. Resp. Dis. 142 895–909 Occurrence Handle2171388 Occurrence Handle1:STN:280:DyaK3M%2FitlOnsg%3D%3D
J.M. White R.J. Irvine (1999) ArticleTitleMechanisms of fatal opioid overdose Addiction 94 961–972 Occurrence Handle10.1046/j.1360-0443.1999.9479612.x Occurrence Handle10707430 Occurrence Handle1:STN:280:DC%2BD3c7nt1Chsw%3D%3D
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Foster, D.J.R., Upton, R.N., Somogyi, A.A. et al. The Acute Disposition of (R)- and (S)-Methadone in Brain and Lung of Sheep. J Pharmacokinet Pharmacodyn 32, 547–570 (2005). https://doi.org/10.1007/s10928-005-0056-9
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10928-005-0056-9